A detailed history of Rakuten Securities, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Rakuten Securities, Inc. holds 2 shares of CTLT stock, worth $114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 1,021 99.8%
Holding current value
$114
Previous $45.9 Million 99.75%
% of portfolio
0.0%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$42.56 - $59.82 $43,368 - $60,956
-1,019 Reduced 99.8%
2 $113,000
Q4 2023

Jan 30, 2024

BUY
$32.18 - $46.57 $32,855 - $47,547
1,021 New
1,021 $45.9 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.3B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.